1-3 of 3
gadolinium-based contrast agents
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Absence of T1 Hyperintensity in the Brain of Thalassemia Patients after Multiple Administrations of Gadobutrol

Antonella Meloni, PhD, Domenico Montanaro, Daniele De Marchi, Maria Chiara Resta, Petra Keilberg, Laura Pistoia, MD, Anna Spasiano, Tommaso Casini, Caterina Cinzia De Bari, Sara De Cori, Vincenzo Positano, Paolo Di Bartolomeo, MD, Alessia Pepe, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4767.
https://doi.org/10.1182/blood.V130.Suppl_1.4767.4767
Published: 2017
Journal Articles

Iron-Oxide Nanoparticles as Magnetic Resonance Contrast Agents: Expanding Their Potential Beyond Iron Replacement Therapy.

Nancy D Doolittle, Ph.D., Edit Dosa, M.D., Edward A Neuwelt, M.D.
Journal: Blood
Blood (2009) 114 (22): 1998.
https://doi.org/10.1182/blood.V114.22.1998.1998
Published: 2009
Journal Articles

High Definition Contrast-Enhanced MR Imaging in Paroxysmal Nocturnal Hemoglobinuria (PNH) Suggests a High Frequency of Subclinical Thrombosis.

Anita Hill, MD, Scott A. Reid, PhD, Russell P. Rother, PhD, Mark T. Gladwin, MD, Paul O. Collinson, PhD, David C. Gaze, PhD, Angela Lowe, DCR, Ashley Guthrie, FRCR, Mohan U. Sivananthan, MD, Peter Hillmen, PhD
Journal: Blood
Blood (2006) 108 (11): 979.
https://doi.org/10.1182/blood.V108.11.979.979
Published: 2006